NETRIS PHARMA has a total of 53 patent applications. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are BENHEALTH BIOPHARMACEUTIC SHENZHEN CO LTD, AUREALIS OY and BICYCLETX LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Canada | 4 | |
#4 | China | 4 | |
#5 | United States | 4 | |
#6 | Republic of Korea | 3 | |
#7 | Argentina | 2 | |
#8 | Australia | 2 | |
#9 | Brazil | 2 | |
#10 | Mexico | 2 | |
#11 | Singapore | 2 | |
#12 | Taiwan | 2 | |
#13 | South Africa | 2 | |
#14 | Chile | 1 | |
#15 | EAPO (Eurasian Patent Organization) | 1 | |
#16 | Hong Kong | 1 | |
#17 | Hungary | 1 | |
#18 | Israel | 1 | |
#19 | Philippines | 1 | |
#20 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Mehlen Patrick | 25 |
#2 | Delcros Jean-Guy | 19 |
#3 | Nony Pascale | 18 |
#4 | Dean Yann | 15 |
#5 | Paradisi Andrea | 6 |
#6 | Delcros Jean Guy | 6 |
#7 | Gibert Benjamin | 5 |
#8 | Bernet Agnes | 5 |
#9 | Goldschneider David | 5 |
#10 | Redavid Anna Maria Rita | 5 |
Publication | Filing date | Title |
---|---|---|
TW201720459A | Combination therapy of NTN1 neutralizing agent with drugs inhibiting epigenetic control | |
EP2893939A1 | Anti-netrin-1 antibody | |
EP2708241A1 | Recombinant Fc-fusion protein of the two Immunoglobulin domains of UNC5 | |
EP2708231A1 | Combined treatment with netrin-1 interfering drug and chemotherapeutic drug | |
EP2407173A1 | Method and compositions to induce apoptosis of tumoral cells expressing SHH | |
EP2385121A1 | Antagonists of Sema3E/PlexinD1 interaction as anti-cancer agents |